Tokyo Tape
Sign in
← Santen Pharmaceutical

Quarterly report · Q2

4536.TEDINET S100PIVT
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥128.9bn2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥63.4bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥266.3bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥128.8bn2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥63.8bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income−¥19.0bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income−¥27.4bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥18.8bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥9.7bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax−¥19.1bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥28.2bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥35.6bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥18.4bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥9.2bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)−¥22.0bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥28.7bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥27.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥14.3bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥7.0bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income−¥22.0bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income−¥28.7bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥14.3bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥6.9bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥426.6bnat 2022-09-30Cons.Assets IFRS
Total assets¥460.0bnat 2022-03-31Cons.Assets IFRS
Total assets¥420.4bnat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥117.2bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥123.1bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥309.4bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥336.8bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥319.0bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥309.6bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥310.1bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥337.5bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥319.6bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥69.1bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥83.0bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥76.0bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥62.9bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥18.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥46.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥27.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥18.8bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥35.2bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥17.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥16.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥5.6bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥3.0bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-56.052022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-75.562022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥68.072021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥35.792021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥17.432021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥-56.052022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-75.562022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥67.972021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥35.732021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥17.392021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio72.7%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio73.4%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio76.0%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 655
ItemContextValueUnit
Cost of sales IFRSCurrentYTDDuration55902000000JPY
Gross profit IFRSPrior1YTDDuration75891000000JPY
Gross profit IFRSCurrentYTDDuration73013000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration39652000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration42296000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration12338000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration14267000000JPY
Amortization on intangible assets associated with products IFRSPrior1YTDDuration4787000000JPY
Amortization on intangible assets associated with products IFRSCurrentYTDDuration5166000000JPY
Other income IFRSPrior1YTDDuration203000000JPY
Other income IFRSCurrentYTDDuration260000000JPY
Other expenses IFRSPrior1YTDDuration512000000JPY
Other expenses IFRSCurrentYTDDuration30566000000JPY
Operating profit loss IFRSPrior1YTDDuration18805000000JPY
Operating profit loss IFRSCurrentYTDDuration-19021000000JPY
Finance income IFRSPrior1YTDDuration672000000JPY
Finance income IFRSCurrentYTDDuration1245000000JPY
Finance costs IFRSPrior1YTDDuration440000000JPY
Finance costs IFRSCurrentYTDDuration262000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration-643000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration-1064000000JPY
Profit loss before tax IFRSPrior1YTDDuration18393000000JPY
Profit loss before tax IFRSCurrentYTDDuration-19103000000JPY
Income tax expense IFRSPrior1YTDDuration4139000000JPY
Income tax expense IFRSCurrentYTDDuration2917000000JPY
Profit loss IFRSPrior1YTDDuration14254000000JPY
Profit loss IFRSCurrentYTDDuration-22019000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration-134000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration2092000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration653000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration10052000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration85000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration1464000000JPY
Other comprehensive income IFRSPrior1YTDDuration604000000JPY
Other comprehensive income IFRSCurrentYTDDuration13607000000JPY
Comprehensive income IFRSPrior1YTDDuration14858000000JPY
Comprehensive income IFRSCurrentYTDDuration-8412000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration14307000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration-22041000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration-53000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration22000000JPY
Profit loss IFRSPrior1YTDDuration14254000000JPY
Profit loss IFRSCurrentYTDDuration-22019000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration14927000000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration-8400000000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1YTDDuration-69000000JPY
Comprehensive income attributable to non controlling interests IFRSCurrentYTDDuration-12000000JPY
Comprehensive income IFRSPrior1YTDDuration14858000000JPY
Comprehensive income IFRSCurrentYTDDuration-8412000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration35.79

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass